EU Draft Proposal For A Compromise Solution

January 7, 2003

Draft proposal for a compromise solution, which should take the form of a footnote to the draft prtosal of 16 December 2002

1 (a) "pharmaceutical product" means any patented product, or product manuactured through a patented process, of the pharmaceutical sector needed to address the public health problems as recognised in paragraph 1 of the Declaration (1). It is understood that active ingredients necessary for its manufacture and diagnostic kits needed for its use would be included;

(1) This covers at least HIV/AIDS, malaria, tuberculosis, yellow fever, plague, cholera, meningococcal disease, African trypanosomiasis, dengue, influenza, leishmaniasis, hepatitis, leptospirosis, pertussis, poliomyelitis, schistosomiasis, typhoid fever, typhus, measles, shigellosis, haemorrhagic fevers and arboviruses. When requested by a Member, the World Health Organization shall give its advice as to the occurrence in an importing Member, or the likelihood thereof, of any other public health problem

Return to: CPTech Home -> Main IP Page -> CPTech Page on WTO -> Paragraph Six Page -> Scope of Diseases Page